Chronic pain is a complex and often debilitating condition that affects millions of people worldwide. Understanding the neurophysiological mechanisms underlying chronic pain is crucial for ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

A dysfunctional signaling pathway in the hippocampus has been linked to chronic pain-related memory impairment in mice.

Having lived with disabling chronic pain for 32 years, one reader discovered a lesser known treatment that has transformed ...

Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic <a target=_blank href= ...

Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.